반응식
[Cl:1][C:2]1[CH:10]=[CH:9][CH:8]=[C:7]2[C:3]=1[CH:4]=[CH:5][N:6]2[C@@H:11]1[O:28][C@H:27]([CH2:29][O:30][C:31](=[O:33])[CH3:32])[C@@H:22]([O:23][C:24](=[O:26])[CH3:25])[C@H:17]([O:18][C:19](=[O:21])[CH3:20])[C@H:12]1[O:13][C:14](=[O:16])[CH3:15].[CH2:34]([O:36][C:37]1[CH:45]=[CH:44][C:40]([C:41](Cl)=[O:42])=[CH:39][CH:38]=1)[CH3:35]>>[CH2:34]([O:36][C:37]1[CH:45]=[CH:44][C:40]([C:41]([C:4]2[C:3]3[C:7](=[CH:8][CH:9]=[CH:10][C:2]=3[Cl:1])[N:6]([C@@H:11]3[O:28][C@H:27]([CH2:29][O:30][C:31](=[O:33])[CH3:32])[C@@H:22]([O:23][C:24](=[O:26])[CH3:25])[C@H:17]([O:18][C:19](=[O:21])[CH3:20])[C@H:12]3[O:13][C:14](=[O:16])[CH3:15])[CH:5]=2)=[O:42])=[CH:39][CH:38]=1)[CH3:35]참가 물질
3
실험 절차
4-Chloro-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-indole obtained in Example 1-(3) and 4-ethoxybenzoyl chloride were treated in a manner similar to Example 2-(4) to give 4-chloro-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-indol-3-yl 4-ethoxyphenyl ketone as a colorless powder. APCI-Mass m/Z 630/632 (M+H). 1H-NMR (DMSO-d6) δ 1.37 (t, J=7.0 Hz, 3H), 1.69 (s, 3H), 1.98 (s, 6H), 2.04 (s, 3H), 4.11-4.12 (m, 2H), 4.14 (q, J=7.3 Hz, 2H), 4.28-4.32 (m, 1H), 5.29 (t, J=9.7 HZ, 1H), 5.54 (t, J=9.5 Hz, 1H), 5.71 (t, J=9.2 Hz, 1H), 6.32 (d, J=9.0 Hz, 1H), 7.04 (d, J=8.8 Hz, 2H), 7.25 (d, J=7.5 Hz, 1H), 7.35 (t, J=8.0 Hz, 1H), 7.79 (d, 1H), 7.99 (d, J=8.8 Hz, 2H), 8.07 (s, 1H).
출처 및 근거
- ORD 기록
- ord-64d67252d9d64ed9b9df6d7557d0b0cb
- 출처 데이터셋
- uspto-grants-2011_05
- 특허 번호
- US07935674B2
연결된 노트
불러오는 중…